FDA Authorizes T-Detect COVID Test
On March 5, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect COVID Test developed by Adaptive Biotechnologies. The…
Products
Duchenne Muscular Dystrophy Mutation Treatment
The U.S. Food and Drug Administration (FDA) recently granted approval for Amondys 45 (casimersen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients…
FDA Approves Cosela
On February 12, the U.S. Food and Drug Administration (FDA) approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of…
COVID-19 Diagnostic Testing Expansion By Aegis
On February 11, Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, and Walgreens announced…
Janssen COVID-19 Vaccine Candidate
On January 29, Johnson & Johnson company announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose…
FDA Approves Cabenuva: First ER, Injectable Drug Regimen for Adults With HIV
On January 2, the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human…
CVS Health’s Symphony For Senior Safety
CVS Health announces about launching the CVS Health’s Symphony, medical alert system to help caregivers monitor the safety and well-being of loved ones, even from…
Moderna’s COVID-19 Vaccine Supply Update
Moderna, Inc., provided a supply update for the Moderna’s COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021….
Novavax Announces Initiation of PREVENT-19 Trial
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced initiation of PREVENT-19, its pivotal Phase 3 study in the United…
Pfizer and BioNTech Supply Another 100 Million Doses of COVID-19 Vaccine
Right before Christmas Pfizer Inc. and BioNTech SE announced a second agreement with the U.S. government to supply an additional 100 million doses of the…